Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-02Clinical Trial Update: Staccato Loxapine in Agitation (Proof of Concept) [Phase 2]
Phase 2 proof-of-concept trial assessing Staccato Loxapine for agitation in schizophrenia has completed with results posted.
-
FDA approval · 2017-12-20FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2017-12-20Clinical Trial Update: Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo [Phase 2]
Phase 2 randomized trial evaluating PF-02545920 vs placebo for schizophrenia was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-20Clinical Trial Update: Neurophysiological Targets for Cognitive Training in Schizophrenia [NA]
Completed trial evaluating neurophysiological targets for cognitive training in schizophrenia; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Cognitive-Behavioral Therapy in Veterans With Schizophrenia [NA]
This clinical trial update reports results from a cognitive-behavioral therapy program for veterans with schizophrenia or schizoaffective di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-12-14FDA Approved: DROPERIDOL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a generic version of droperidol under an original application by Hikma Pharmaceuticals USA Inc. This approval adds another gene…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Add-on Methotrexate for the Treatment of Schizophrenia [Phase 2]
A Phase 2 trial is evaluating add-on methotrexate for schizophrenia; no clinical results are provided in the update.
-
FDA approval · 2017-12-11FDA Approved: ARIPIPRAZOLE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma's ARIPIPRAZOLE as an original application generic, allowing marketing for the same indications as the reference prod…
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Varenicline Adjunctive Treatment in Schizophrenia [Phase 4]
Phase 4 trial update on varenicline as an adjunctive treatment in schizophrenia and related disorders completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating pioglitazone for lipid and glucose abnormalities in patients with schizophrenia has completed, with resu…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode [NA]
This completed clinical trial evaluated whether combining exercise with cognitive training improves cognitive and functional outcomes after …
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses [NA]
This ClinicalTrials.gov update indicates that the Johns Hopkins University-sponsored trial 'Peer Support for Increasing Physical Activity in…
-
FDA approval · 2017-12-05FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate from Patriot Pharmaceuticals LLC.
-
FDA approval · 2017-12-04FDA Approved: ARIPIPRAZOLE — Original Application (Solco Healthcare U.S., LLC)
FDA approved ARIPIPRAZOLE from Solco Healthcare U.S., LLC as an original generic application. The approval allows generic aripiprazole for t…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors [Phase 4]
A Phase 4 clinical trial assessing varenicline for cognitive deficits and cigarette smoking in schizophrenia reports efficacy findings and p…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal [Phase 4]
A Phase 4 trial assessing functional brain imaging and employment outcomes in first-episode schizophrenia patients treated with Risperdal ha…
-
FDA approval · 2017-11-30FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic quetiapine under an Original Application (ANDA204253), making a generic version of q…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
FDA approved a generic quetiapine fumarate product from Accord Healthcare Inc. under an original ANDA.
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approves Ingenus Pharmaceuticals' quetiapine fumarate under an Original Application, making a generic version of the antipsychotic avail…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Risperidone LA Heathcare Resource Study [Phase 4]
A Phase 4 post-marketing study of risperidone long-acting injectable conducted by the University of British Columbia has completed. The stud…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE FUMARATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic quetiapine fumarate product from Aurobindo Pharma Limited. Quetiapine is used to treat s…
-
FDA approval · 2017-11-29FDA Approved: QUETIAPINE EXTENDED RELEASE — Original Application (ACI Healthcare USA, Inc.)
FDA approved an original application for quetiapine extended-release (generic) by ACI Healthcare USA, Inc., making a generic version of quet…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Task Sharing for the Care of Severe Mental Disorders in a Low-income Country [Phase 3]
A Phase 3 trial evaluating a task-sharing care model for schizophrenia, bipolar disorder, major depressive disorder, and schizoaffective dis…
-
CLINICAL_TRIALS withdrawal · 2017-11-29Clinical Trial Update: Safety and Tolerability of Varenicline in Schizophrenia (SATOVA) [Phase 4]
A Phase 4 trial evaluating the safety and tolerability of varenicline in schizophrenia and schizoaffective disorder has been withdrawn.